Diwali stocks by Motilal Oswal: Eternal, Adani Ports among 10 stocks with upside of up to 40%. See full list
Motilal Oswal said Samvat 2083 has begun on a cautious note, with an external energy shock weighing on market sentiment despite the resilience of the domestic economy. The West Asia conflict has kept Brent crude prices above $100 per barrel, pushing CPI inflation to 5.54% in September and prompting…
Symbiotec Pharmalab has a target price of Rs 1,430 against its current market price of Rs 1,168, indicating a potential upside of 22%. Its EPS is projected to grow at a CAGR of 23% between FY26 and FY28E, while FY27E RoE is estimated at 10.4%.
Disclaimer: This article has been written by Veer Sharma, who is not a SEBI-registered Research Analyst or an Investment Adviser. Veer Sharma and his/her ‘relative(s)’ (as defined under Section 2(77) of the Companies Act, 2013) do not hold any financial interest in the companies mentioned in this article as of the date of publication. The views/recommendations mentioned in this article, wherever applicable, are those of the respective SEBI-registered Research Analyst/brokerage and have been reproduced/reported with due attribution. They should not be construed as the views or recommendations of The Economic Times Digital or the journalist. Readers are advised to consider the original research report and make their investment decisions based on their own assessment. Brokerage disclaimers here
Source: ET Markets, Mint Markets
Watch: Stock Market News #shorts #mukulagrawal #stockmarket
Disclaimer: This article is for general information and does not constitute investment, tax or legal advice. Markets and rates change; please verify with official sources or a qualified professional before you act.
